What existing evidence establishes
NHS programmes and published studies already show that medicine route, formulation, preparation and delivery model can materially alter nursing preparation time, pharmacy workload and treatment-chair capacity.
Prototype 3 · evidence-backed scenarios
Medicines Resource Intelligence
The NHS has already shown that medicine route, formulation, preparation and delivery model can change nursing, pharmacy, chair and bed resource. Sitora's job is to find those opportunities systematically and verify the local result.
Evidence modelPublished evidence ≠ local saving4 selectable scenariosLocal benefit still requires a measured pilot
1Evidence
2Find
3Approve
4Verify
Subcutaneous cancer treatment at home
Published headline2,520 chair-hours releasedEast and North Hertfordshire Teaching NHS Trust
Additional signal2,520 injections · 196 patientsPublished scenario
Sitora statusOpportunityNot yet local recovery
What the evidence says
NHS England reports that a home subcutaneous cancer-treatment programme delivered 2,520 injections for 196 patients and released 2,520 hospital chair-hours, with no serious safety incidents reported in the programme summary.
What this proves: Changing route and location can release real treatment-chair capacity in an NHS service.
Limitation: This is one programme and should not be generalised to every medicine, cancer pathway or patient cohort.
View source ↗Local implementation
Should this opportunity enter a measured pilot?
Evidence status
Published evidence only
The evidence proves the mechanism is credible. It does not prove that this trust will achieve the same effect.
Sitora pilot measurement
What would have to be observed locally?
Eligibility, administration location, chair hours avoided, staff time, travel burden, adverse events and whether released slots are actually reused.
Evidence ladder
- 1. Established mechanism: published evidence shows the pathway can change resource use.
- 2. Quantified scenario: a study or NHS programme reports the size of the effect in a defined setting.
- 3. Sitora pilot: the local provider measures its own baseline, intervention and balancing measures.
- 4. Verified recovery: released time/capacity is demonstrably reusable and finance validates any monetary claim.
Resource Recovery Record
No imported savings claims.
Published evidence can trigger an investigation. Only observed local change can become a Sitora recovery record.
Evidence sourceEast and North Hertfordshire Teaching NHS Trust
OpportunitySubcutaneous cancer treatment at home
Local statusNot tested
Verified local benefitNot yet established
What counts as verified recovery?
Clinical eligibility confirmed; actual route/formulation/preparation recorded; staff and chair/bed resource measured before and after; safety and patient outcomes monitored; additional workload counted; released capacity shown to be reusable; and any cash claim independently validated by finance.
Evidence → product → proof
Separate what is already established from what Sitora still has to prove.
The published evidence supports the problem or intervention mechanism. A Sitora pilot must establish the local effect.
The product layer
A systematic intelligence layer that scans for those opportunities across a provider's medicines pathways, links each opportunity to relevant evidence, and routes only clinically eligible candidates into measured implementation.
No assumption allowed
Whether the same opportunity exists locally; the true before-and-after staff, chair or bed resource; safety and patient outcomes; additional workload created; whether released capacity is actually reused; and whether any monetary effect is cash-releasing, cost avoidance or capacity only.
The NHS has already shown that medicine pathways can release resource. Sitora's role is to find the right opportunities locally, measure them consistently and prove what was actually recovered.